{"id":"https://openalex.org/W2000659353","doi":"https://doi.org/10.2146/ajhp050119","title":"Development of diabetes after gatifloxacin therapy","display_name":"Development of diabetes after gatifloxacin therapy","alternate_titles":[],"publication_year":2005,"publication_date":"2005-10-28","ids":{"openalex":"https://openalex.org/W2000659353","doi":"https://doi.org/10.2146/ajhp050119","mag":"2000659353","pmid":"https://pubmed.ncbi.nlm.nih.gov/16239422"},"language":"en","primary_location":{"id":"doi:10.2146/ajhp050119","doi":"https://doi.org/10.2146/ajhp050119","is_oa":false,"landing_page_url":"https://doi.org/10.2146/ajhp050119","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000659353"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013822464","display_name":"Julie A. Stading","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Julie A. Stading","raw_affiliation_strings":["School of Pharmacy Practice, Creighton University, Omaha, NE 68178, USA. jstading@ad.creighton.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy Practice, Creighton University, Omaha, NE 68178, USA. jstading@ad.creighton.edu","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038469965","display_name":"Alan W. Y. Chock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan W. Y. Chock","raw_affiliation_strings":["Creighton University;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creighton University;","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059800074","display_name":"Maryann Z. Skrabal","orcid":"https://orcid.org/0000-0001-8315-9022","observed_orcids":["https://orcid.org/0000-0001-8315-9022"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maryann Z. Skrabal","raw_affiliation_strings":["Office of Experiential Education, School of Pharmacy Practice, Creighton University, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Experiential Education, School of Pharmacy Practice, Creighton University, Omaha, NE","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111588147","display_name":"Michele A. Faulkner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele A. Faulkner","raw_affiliation_strings":["School of Pharmacy Practice, Creighton University, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy Practice, Creighton University, Omaha, NE","institution_ids":["https://openalex.org/I114493937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013822464"],"corresponding_institution_ids":["https://openalex.org/I114493937"],"apc_list":{"value":4448,"currency":"USD","value_usd":4448},"apc_paid":null,"fwci":1.3868,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.75829384,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"62","issue":"21","first_page":"2293","last_page":"2295"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.13899999856948853,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gatifloxacin","display_name":"gatifloxacin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8820000290870667},{"id":"https://openalex.org/keywords/drug-induced-diabetes","display_name":"drug-induced diabetes","score":0.8500000238418579},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7879999876022339},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.800000011920929},{"id":"https://openalex.org/keywords/cellulitis","display_name":"cellulitis","score":0.6650000214576721},{"id":"https://openalex.org/keywords/leg-ulcers","display_name":"leg ulcers","score":0.5249999761581421},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.6349999904632568},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7549999952316284},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.4740000069141388},{"id":"https://openalex.org/keywords/cephalexin","display_name":"cephalexin","score":0.5189999938011169},{"id":"https://openalex.org/keywords/amoxicillin-clavulanic-acid","display_name":"amoxicillin-clavulanic acid","score":0.9350000023841858},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.5619999766349792},{"id":"https://openalex.org/keywords/gastroesophageal-reflux-disease","display_name":"gastroesophageal reflux disease","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9356092810630798},{"id":"https://openalex.org/C2777653605","wikidata":"https://www.wikidata.org/wiki/Q2365016","display_name":"Gatifloxacin","level":4,"score":0.8097586035728455},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.7778565287590027},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6972662210464478},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4712035357952118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4299294948577881},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3285069465637207},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.17102009057998657},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.10999923944473267},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077734","descriptor_name":"Gatifloxacin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002481","descriptor_name":"Cellulitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007871","descriptor_name":"Leg Ulcer","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2146/ajhp050119","doi":"https://doi.org/10.2146/ajhp050119","is_oa":false,"landing_page_url":"https://doi.org/10.2146/ajhp050119","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},{"id":"pmid:16239422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16239422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W2067978628","https://openalex.org/W2101529051","https://openalex.org/W2149481139"],"related_works":["https://openalex.org/W2408839686","https://openalex.org/W2051923650","https://openalex.org/W33334988","https://openalex.org/W1991207062","https://openalex.org/W2051413959","https://openalex.org/W2388295071","https://openalex.org/W2159328073","https://openalex.org/W1980667104","https://openalex.org/W2101529051","https://openalex.org/W2170215874"],"abstract_inverted_index":{"The":[0,439,532],"prescribing":[1],"information":[2],"for":[3,177,195,230,270,291,312,331,369,450,502,521,530,548],"gatifloxacin":[4,220],"states,":[5],"\u201cDisturbances":[6],"of":[7,51,60,81,113,125,251,383,428,431,541],"blood":[8,88,317,388],"glucose,":[9],"including":[10],"symptomatic":[11],"hyper-":[12],"and":[13,34,83,168,185,216,228,243,249,281,301,309,329,344,358,377,386,415,435,499,523,543],"hypoglycemia,":[14],"have":[15,183],"been":[16,157,286,442],"reported":[17,424,534],"with":[18,116,122,134,150,159,353,361,410,418],"Tequin,":[19],"usually":[20],"in":[21,27,47,66,76,161,211],"diabetic":[22],"patients.\u201d1":[23],"In":[24,62],"premarketing":[25],"studies":[26],"16":[28],"type":[29,67,354,411,419],"2":[30,68,355,412],"diabetes":[31,69,114,356,384,413,421],"mellitus":[32,70,357,414],"patients":[33,73],"30":[35],"healthy":[36],"volunteers,":[37],"the":[38,72,77,131,142,148,205,212,252,278,307,327,332,346,393,444,537],"serum":[39,48],"glucose":[40,89,95,318,389],"levels":[41,50,90,96],"decreased":[42],"by":[43,236],"30%":[44],"following":[45,445],"increases":[46],"insulin":[49,362],"20\u201340%":[52],"after":[53,103,345],"an":[54,110,247],"initial":[55],"oral":[56],"or":[57],"intravenous":[58],"dose":[59,540],"gatifloxacin.":[61,117],"one":[63,408,416],"postmarketing":[64],"study":[65],"patients,":[71],"experienced":[74],"hypoglycemia":[75],"first":[78],"two":[79],"days":[80,102,197,245],"therapy,":[82],"then":[84],"from":[85,92,130,138,398],"day":[86,176,194,225,434],"3":[87],"increased":[91],"baseline.":[93],"Blood":[94],"returned":[97],"to":[98,141,147,182,293,326,400],"baseline":[99],"within":[100],"28":[101],"therapy":[104],"was":[105,145,226,234,254,310,320,324,351,359,367],"discontinued.1":[106],"We":[107],"report":[108],"here":[109],"apparent":[111],"case":[112],"associated":[115],"A":[118,207],"57-year-old":[119],"Caucasian":[120],"man":[121],"a":[123,126,175,193,224,237,429],"history":[124,366,382],"left":[127,163,214],"leg":[128,164],"wound":[129],"Vietnam":[132],"war":[133],"resulting":[135],"periodic":[136],"swelling":[137],"traumatic":[139],"injury":[140],"femoral":[143],"artery":[144],"admitted":[146,325],"hospital":[149,328,348],"hyperglycemia":[151],"on":[152,165,199,204,217,240,272],"May":[153,276],"19.":[154,274],"He":[155,180,233,256,304,323,350,379,403,423],"had":[156,285,380,407,441],"diagnosed":[158,352],"cellulitis":[160],"his":[162,316],"March":[166,200],"25":[167,526],"received":[169,186,257],"cephalexin":[170],"500":[171,261],"mg":[172,190,222,262,457,462,468,473,479,486,491,496,510,527],"four":[173,517],"times":[174,192,475,481],"10":[178,196,231,456],"days.":[179,232],"continued":[181,229],"problems":[184],"amoxicillin\u2013clavulanate":[187],"potassium":[188],"875":[189],"three":[191,426,474,480],"starting":[198],"29":[201],"while":[202],"continuing":[203],"cephalexin.":[206],"1-cm":[208],"ulcer":[209],"developed":[210],"patient\u2019s":[213,347],"leg,":[215],"April":[218,241,273],"13":[219],"400":[221],"once":[223],"initiated":[227],"evaluated":[235],"vascular":[238],"surgeon":[239],"14,":[242],"five":[244,292],"later":[246],"incision":[248],"drainage":[250],"site":[253],"performed.":[255],"hydrocodone":[258],"5":[259],"mg\u2013acetaminophen":[260],"1\u20132":[263],"tablets":[264],"every":[265,497,516],"six":[266,453],"hours":[267,518],"as":[268,500,519,528],"needed":[269,501,520,529],"pain":[271,296],"On":[275],"19":[277],"patient":[279,440,533],"telephoned":[280],"stated":[282,404],"that":[283,405],"he":[284,406],"having":[287],"more":[288],"frequent":[289],"urination":[290],"seven":[294],"days,":[295],"during":[297,343],"urination,":[298],"blurry":[299],"vision,":[300],"extreme":[302],"thirst.":[303],"came":[305],"into":[306],"clinic":[308],"negative":[311],"urinary-tract":[313],"infection,":[314],"but":[315],"concentration":[319],"992":[321],"mg/dL.":[322,402],"monitored":[330],"next":[333],"week.":[334],"Table":[335],"11":[336],"provides":[337],"pertinent":[338],"laboratory":[339],"test":[340],"values":[341],"obtained":[342,391],"stay.":[349],"treated":[360],"therapy.":[363],"His":[364],"medical":[365],"significant":[368],"osteoarthritis,":[370],"gastroesophageal":[371],"reflux":[372],"disease,":[373],"impotence,":[374],"migraines,":[375],"hypertension,":[376],"hyperlipidemia.":[378],"no":[381],"mellitus,":[385],"fasting":[387],"concentrations":[390],"over":[392],"previous":[394],"several":[395],"years":[396],"ranged":[397],"103":[399],"116":[401],"grandmother":[409],"son":[417],"1":[420],"mellitus.":[422],"smoking":[425],"fourths":[427],"pack":[430],"cigarettes":[432],"per":[433],"denied":[436,544],"alcohol":[437],"use.":[438],"taking":[443,535,545],"medications":[446],"at":[447,458,492],"stable":[448],"dosages":[449],"longer":[451],"than":[452],"months:":[454],"simvastatin":[455],"bedtime,":[459,493],"ranitidine":[460],"150":[461],"twice":[463,469],"daily,":[464,470,476,482,487],"metoprolol":[465],"tartrate":[466],"100":[467,490],"niacin":[471],"1500":[472],"indomethacin":[477],"50":[478,507],"docusate":[483],"sodium":[484],"200":[485],"amitriptyline":[488],"hydrochloride":[489,525],"furosemide":[494,542],"20":[495],"morning":[498,539],"swelling,":[503],"aspirin":[504],"325":[505],"mg/butalbital":[506],"mg/caffeine":[508],"40":[509],"(Fiorinal,":[511],"Watson":[512],"Pharmaceuticals,":[513],"Corona,":[514],"CA)":[515],"headache,":[522],"diphenhydramine":[524],"insomnia.":[531],"only":[536],"scheduled":[538],"additional":[546],"doses":[547],"swelling.":[549]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000659353","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
